ENKINDA

Serial Number 85913455
606

Registration Progress

Application Filed
Apr 24, 2013
Under Examination
Nov 12, 2013
Approved for Publication
Sep 17, 2013
Published for Opposition
Sep 17, 2013
Registered

Trademark Image

ENKINDA

Basic Information

Serial Number
85913455
Filing Date
April 24, 2013
Published for Opposition
September 17, 2013
Abandonment Date
December 19, 2016
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 19, 2016
Classes
005

Rights Holder

Eli Lilly and Company

03
Address
Lilly Corporate Center
Indianapolis, IN 46285

Ownership History

Eli Lilly and Company

Original Applicant
03
Indianapolis, IN

Eli Lilly and Company

Owner at Publication
03
Indianapolis, IN

Legal Representation

Attorney
Robert E. Lee, Jr.

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

31 events
Date Code Type Description Documents
Dec 19, 2016 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 19, 2016 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Mar 29, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 28, 2016 EX5G S SOU EXTENSION 5 GRANTED Loading...
Mar 25, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 25, 2016 EXT5 S SOU EXTENSION 5 FILED Loading...
Oct 2, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 1, 2015 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 29, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 29, 2015 EXT4 S SOU EXTENSION 4 FILED Loading...
May 5, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 4, 2015 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 27, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 27, 2015 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 5, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 4, 2014 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 31, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 31, 2014 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 18, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 17, 2014 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 16, 2014 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 24, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 24, 2014 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 12, 2013 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 17, 2013 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 17, 2013 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 28, 2013 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 11, 2013 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 11, 2013 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 1, 2013 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 27, 2013 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, sleep disorders, urological disorders; antidepressants
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005